Company profile
Exploris Health AG
Coronary heart disease is still the leading cause of death worldwide. So far there has been no simple and accurate test for fast detection of life-threatening narrowing of the heart arteries. Cardio Explorer is the first simple AI-based cardiovascular diagnostic test for the current detection/exclusion of life-threatening constriction of the heart arteries (reason for heart infarction). Cardio Explorer has been validated in three clinical studies and is more accurate than the often-applied stress ECG. Cardio Explorer has received the Swiss Biolabs Award 2018 and the second prize at the IFAS Innovation Challenge 2018.
Source: startup.ch
The new Swiss Venture Capital Report was published on 26 January. It analyses 304 financing rounds closed in 2020 and includes further article such as an interview with Michael Hengartner, President of the ETH Board, and a list of Swiss "soonicorns". 
